Levodopa toxicity in Parkinson disease: reality or myth? Reality--practice patterns should change.
Shulman
L M
LM
Department of Neurology, University of Miami School of Medicine, Fla 33136, USA.
D000978:Antiparkinson Agents / Q000009:adverse effects*; D003937:Diagnosis, Differential; D018450:Disease Progression; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy*; D012107:Research Design; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D007980:Levodopa